Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer

Journal of Obstetrics and Gynaecology Research

Volumn 40, Issue 1, 2014, Pages 178-183

  Ma, Xuegong ^a   Wang, Yingmei ^a   Sheng, Hongna ^a   Tian, Wenyan ^a   Qi, Zheng ^a   Teng, Fei ^a   Xue, Fengxia ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial ovarian cancer; Platelet aggregation rate; Prognosis; Thrombocytosis

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; OVARY CARCINOMA; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PROGRESSION FREE SURVIVAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; THROMBOCYTOSIS;

EPITHELIAL OVARIAN CANCER; PLATELET AGGREGATION RATE; PROGNOSIS; THROMBOCYTOSIS;

BLOOD PLATELET DISORDERS; CHINA; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; PLATELET AGGREGATION; PLATELET COUNT; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOCYTOSIS;

EID: 84897070848     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.12151     Document Type: Article

References (21)

1. Pedersen LM, Milman N. Diagnostic significance of platelet count and other blood analyses in patients with lung cancer. Oncol Rep 2003; 10: 213-216.
2. Naschitz JE, Yeshurun D, Eldar S et al. Diagnosis of cancer associated vascular disorders. Cancer 1996; 77: 1759-1767.
3. Hernandez E, Donohue KA, Anderson LL et al. The significance of thrombocytosis in patients with locally advanced cervical carcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 2000; 78: 137-142.
4. Borsig L. The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther 2008; 8: 1247-1255.
5. Bambace NM, Holmes CE. The platelet contribution to cancer progression. J Thromb Haemost 2011; 9: 237-249.
6. Wu S, Zheng D, Lin Q. Clinical study on hemorrheologic changes for metastatic state of gastric cancer and its relationship with syndrome-type in traditional Chinese medicine. Zhongguo Zhong Xi Yi Jie He Za Zhi 2000; 20: 583-585.
7. Cakar B, Karaoglanoglu M, Sayici Y et al. The prognostic value of thrombocytosis in newly diagnosed lung cancer patients: A retrospective analysis. J BUON 2011; 16: 677-681.
8. Taucher S, Salat A, Gnant M et al. Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost 2003; 89: 1098-1106.
9. Gorelick C, Andikyan V, Mack M et al. Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population. Int J Gynecol Cancer 2009; 19: 1384-1389.
10. Qiu J, Yu Y, Fu Y et al. Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer. J Obstet Gynaecol Res 2012; 38: 651-657.
11. Soonthornthum T, Suraseraneewong V, Kengsakol K et al. Thrombocytosis in advanced epithelial ovarian cancer. J Med Assoc Thai 2007; 90: 1495-1500.
12. Zeimet AG, Marth C, Muller-Holzner E et al. Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 1994; 170: 549-554.
13. Li AJ, Madden AC, Cass I et al. The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol 2004; 92: 211-214.
14. Lee M, Kim SW, Nam EJ et al. The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer. Gynecol Oncol 2011; 122: 238-241.
15. Gungor T, Kanat-Pektas M, Sucak A et al. The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors. Arch Gynecol Obstet 2009; 279: 53-56.
16. Stone RL, Nick AM, McNeish IA et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 2012; 366: 610-618.
17. Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A 1968; 61: 46-52.
18. Chang MC, Chan CP, Ho YS et al. Signaling pathways for induction of platelet aggregation by SAS tongue cancer cells - a mechanism of hematogenous metastasis. J Oral Pathol Med 2009; 38: 434-440.
19. Timar J, Tovari J, Raso E et al. Platelet-mimicry of cancer cells: Epiphenomenon with clinical significance. Oncology 2005; 69: 185-201.
20. Wenzel J, Zeisig R, Fichtner I. Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions. Clin Exp Metastasis 2010; 27: 25-34.
21. Franchini M, Montagnana M, Favaloro EJ et al. The bidirectional relationship of cancer and hemostasis and the potential role of anticoagulant therapy in moderating thrombosis and cancer spread. Semin Thromb Hemost 2009; 35: 644-653.